Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase IV serum-donor study of Menveo versus Bexsero in healthy adults
2017-002919-33Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2017
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meningococcal A conjugate vaccine and meningococcal group B vaccine in meningococcal disease (2 arms), sponsored by GSK. Primary endpoint: Collection of human blood for conversion into serum. Started Nov 2017; status: completed.
02
Drugs
meningococcal A conjugate vaccinemeningococcal group B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2017-002919-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002919-33.